Total Payments
$500.25
2023 Payments
$42.22
Companies
9
Transactions
47
Medicare Patients
472
Medicare Billing
$41,797
Payment Breakdown by Category
Food & Beverage$500.25 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $500.25 | 47 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $233.08 | 31 | $0 (2022) |
| Alkermes, Inc. | $67.27 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $54.68 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $46.35 | 3 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $26.87 | 2 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.98 | 1 | $0 (2022) |
| ITI, Inc. | $18.78 | 1 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $16.56 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $14.68 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $42.22 | 2 | Janssen Pharmaceuticals, Inc ($23.44) |
| 2022 | $177.80 | 10 | Otsuka America Pharmaceutical, Inc. ($46.35) |
| 2021 | $280.23 | 35 | AbbVie Inc. ($207.60) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Neuroscience | ||||||
| 03/31/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: PSYCHIATRY | ||||||
| 08/11/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: PSYCHIATRY | ||||||
| 07/14/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: PSYCHIATRY | ||||||
| 07/07/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: CNS | ||||||
| 06/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Central Nervous System | ||||||
| 05/26/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: CNS | ||||||
| 05/11/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Neuropsychiatry | ||||||
| 04/14/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Neuropsychiatry | ||||||
| 02/07/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Neuroscience | ||||||
| 10/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: CNS | ||||||
| 08/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: CNS | ||||||
| 07/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 30 | 33 | $6,638 | $2,131 |
| 2022 | 3 | 44 | 71 | $12,769 | $4,442 |
| 2021 | 6 | 149 | 339 | $53,200 | $14,070 |
| 2020 | 7 | 249 | 482 | $41,144 | $21,153 |
Total Patients
472
Total Services
925
Medicare Billing
$41,797
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 18 | 18 | $5,760 | $1,792 | 31.1% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 12 | 15 | $877.98 | $338.88 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 41 | $7,346 | $2,440 | 33.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 14 | 15 | $4,633 | $1,593 | 34.4% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2022 | 11 | 15 | $789.90 | $409.50 | 51.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 164 | $29,266 | $9,322 | 31.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 11 | 21 | $1,672 | $1,305 | 78.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $2,462 | $1,079 | 43.8% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 15 | 84 | $12,096 | $872.07 | 7.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 21 | 27 | $3,240 | $771.47 | 23.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 28 | 31 | $4,464 | $720.84 | 16.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 87 | 181 | $19,406 | $10,161 | 52.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 81 | $5,757 | $3,456 | 60.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 43 | 46 | $5,627 | $3,136 | 55.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 26 | 33 | $3,354 | $1,686 | 50.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $3,021 | $1,317 | 43.6% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 15 | 94 | $3,154 | $1,114 | 35.3% |
| 90853 | Group psychotherapy | Office | 2020 | 16 | 35 | $825.18 | $281.67 | 34.1% |
About Robert Seigel
Robert Seigel is a Psychiatric/Mental Health healthcare provider based in Hampstead, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912043050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Seigel has received a total of $500.25 in payments from pharmaceutical and medical device companies, with $42.22 received in 2023. These payments were reported across 47 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($500.25).
As a Medicare-enrolled provider, Seigel has provided services to 472 Medicare beneficiaries, totaling 925 services with total Medicare billing of $41,797. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health, Psychiatric/Mental Health
- Location Hampstead, NC
- Active Since 01/29/2007
- Last Updated 01/29/2026
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912043050
Products in Payments
- VRAYLAR (Drug) $233.08
- ARISTADA (Drug) $49.12
- REXULTI (Drug) $31.35
- INVEGA SUSTENNA (Drug) $31.24
- INGREZZA (Drug) $26.87
- SPRAVATO (Drug) $23.44
- VYVANSE (Drug) $21.98
- CAPLYTA (Drug) $18.78
- LYBALVI (Drug) $18.15
- HETLIOZ (Drug) $16.56
- ABILIFY MAINTENA (Drug) $15.00
- AUSTEDO (Drug) $14.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Hampstead
Mrs. Colette Tefft, Cns, CNS
Psychiatric/Mental Health — Payments: $2,003
Psychiatric/Mental Health $2,003
Dr. Anna Alban, Dnp, Pmhnp-Bc, DNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $104.50
Psychiatric/Mental Health $104.50
Pamela Nazarov
Psychiatric/Mental Health — Payments: $21.01
Psychiatric/Mental Health $21.01
Julie Twigg, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health
Psychiatric/Mental Health
Kristina Norman
Psychiatric/Mental Health
Psychiatric/Mental Health